PDRG, a novel tumor marker for colorectal cancer.

被引：0
|
作者：
Jiang, Lingyan [1 ]
Luo, Xiuquan [1 ]
Shi, Jingxue [1 ]
Sun, Hong [1 ]
Huang, Ying [1 ]
Sheikh, M. Saeed [1 ]
机构：
[1] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1804
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A novel distant metastasis-related marker in colorectal cancer.
    Yoshikawa, R
    Tamaoki, TH
    Yanagi, H
    Noda, M
    Fujiwara, Y
    Gega, M
    Oshima, T
    Yamamura, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 882S - 882S
  • [2] CA 11-19 as a tumor marker for the diagnosis of colorectal cancer.
    Overholt, Bergein F.
    Jordan, Tommye
    Wheeler, Donald J.
    Fritsche, Herbert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Estrogen receptor beta as a marker of tumor progression and prognosis in colorectal cancer.
    Stevanato Filho, Paulo Roberto
    Aguiar, Samuel
    Begnami, Maria D.
    Ferreira, Fabio Oliveira
    Nakagawa, Wilson Toshihiko
    Sobreira Batista, Ranyell Spencer
    Melio, Celso Lopes
    Lopes, Ademar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A NOVEL SIEROLOGICAL INFLAMMATORY SCORE AS POSSIBLE PROGNOSTIC MARKER IN COLORECTAL CANCER.
    Di Caro, G.
    Carvello, M.
    Pesce, S.
    Sacchi, M.
    Erreni, M.
    Marchesi, F.
    Allavena, P.
    Montorsi, M.
    Spinelli, A.
    [J]. DISEASES OF THE COLON & RECTUM, 2015, 58 (05) : E361 - E361
  • [5] Dachshund 2 protein, a novel neuroendocrine marker associated with favorable tumor characteristics and clinical outcome in colorectal cancer.
    Wangefjord, Sakarias
    Brunnstrom, Hans
    Nodin, Bjorn
    Uhlen, Mathias
    Eberhard, Jakob
    Jirstrom, Karin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Identification of Cystatin SN as a novel tumor marker for colorectal cancer
    Yoneda, Kyoko
    Iida, Hiroshi
    Endo, Hiroki
    Hosono, Kunihiro
    Akiyama, Tomoyuki
    Takahashi, Hirokazu
    Inamori, Masahiko
    Abe, Yasunobu
    Yoneda, Masato
    Fujita, Koji
    Kato, Shingo
    Nozaki, Yuichi
    Ichikawa, Yasushi
    Uozaki, Hiroshi
    Fukayama, Masashi
    Shimamura, Takahiro
    Kodama, Tatsuhiko
    Aburatani, Hiroyuki
    Miyazawa, Chihiro
    Ishii, Keisuke
    Hosomi, Naoki
    Sagara, Mina
    Takahashi, Masazumi
    Ike, Hideyuki
    Saito, Hiroaki
    Kusakabe, Akihiko
    Nakajima, Atsushi
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (01) : 33 - 40
  • [7] DNA integrity as a novel marker for stool-based detection of colorectal cancer.
    Boynton, KA
    Summerhayes, IC
    Ahlquist, D
    Shuber, AP
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1200S - 1200S
  • [8] NTRK3 as a novel tumor suppressor gene in colorectal cancer.
    Luo, Yanxin
    Kaz, Andrew
    Kanngurn, Samornmas
    Grady, William M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] The tumor metabolic marker tumor M2-PK in stool: A new biomarker for colorectal cancer.
    Kloer, HU
    Hardt, PD
    Schlierbach, P
    Toepler, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 270S - 270S
  • [10] PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress
    Jiang, Lingyan
    Luo, Xiuquan
    Shi, Jingxue
    Sun, Hong
    Sun, Qing
    Sheikh, M. Saeed
    Huang, Ying
    [J]. CANCER BIOLOGY & THERAPY, 2011, 11 (06) : 567 - 573
12345